流感抗原现货库存：

09/274  Influenza Virus Infectious NYMC X-185
98/762  Influenza Virus infectious Resvir-14 (H3N2)
90/784  Influenza Virus infectious NIB-26 (H3N2)
05/102  Influenza Virus infectious NYMC BX-7
12/202  Influenza virus infectious NYMC BX-39
00/530  Influenza Virus infectious B/Sichuan/379/99
05/138  Influenza Virus infectious B/Shanghai/361/2002
12/202  Influenza virus infectious NYMC BX-39
13/116  Influenza Antigen A/Texas/50/2012 (NYMC X-223A)
92/734  Influenza Virus infectious A/Beijing/32/92 (H3N2)
92/738  Influenza Virus infectious A/Shanghai/24/90
93/568  Influenza Virus infectious A/Beijing/359/89 (H3N2)
93/572  Influenza Virus infectious A/Guizhou/54/89 (H3N2)
93/686  Influenza Virus infectious A/Shangdong/9/93 (H3N2)
95/758  Influenza Virus infectious A/Wuhan/359/95 (H3N2)
98/778  Influenza Virus infectious A/Sichuan/346/98 (H3N2)

其他抗原抗体库存：

97/648  Anti-Measles serum
RAI     Anti-rabies Immunoglobulin, Human
83/575  Follicle Stimulating Hormone, Pituitary
06/166  Antithrombin Concentrate, Human
90/636  HIV-1 P24 Antigen
08/258  Antithrombin, Plasma (3rd International Standard)

13/242  FEIBA Concentrate 2nd NIBSC Working Reference Standard
92/680  Serum amyloid A protein. WHO International Standard
92/644  Interleukin-1 receptor antagonist (Human rDNA derived)
05/112  Low Molecular Weight Heparin for Molecular Weight Calibration(2nd International Standard)
08/282  Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)
10/266  4th WHO International Standard for HBV DNA for NAT
14/150  Hepatitis C virus (HCV) For nucleic acid amplification techniques (5th International standard 2015)
13/146  C-Peptide, Human. 1st International Standard
93/556  Nerve Growth Factor (Human, rDNA derived)
16/194  HIV-1 RNA 4th International Standard
AFP(72/225)  Alpha-Foetoprotein
83/500  Insulin, Human
09/296  1st International Standard for human Proinsulin
83/573(84/500)  Prolactin, Human
96/668  Prostate-Specific Antigen Free
10/152  Candidate HIV-1 RNA 3rd International Standard
PPDBOV  Purified Protein Derivative (PPD) of Bovine Tuberculin WHO International Standard
PPDA  Purified Protein Derivative (PPD) of M Avium Tuberculin WHO International Standard
67/182  Anti-Rubella Serum, Human
12/226  HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)
93/526  Batroxobin
10/266 (10/264)  Hepatitis B Virus for Nucleic Acid Amplification Techniques (3rd WHO International Standard)
07/164  Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)
09/260  Epstein-Barr Virus (1st International Standard)
B2M  Beta-2 Microglobulin
75/595  Blood Coagulation Factor Xa, Bovine
13/100  Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)
12/224  HIV-1 NAT subtypes (Main)(2nd International Reference Preparationl)
14/290  4th HCV RNA Genotype Panel for Nucleic Acid Amplification
11/234(75/502)  Serum Immunoglobulin E (IgE) Human
88/646  Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived) WHO International Standard
87/640  Tumour Necrosis Factor beta (Human, rDNA derived) WHO Reference Reagent
85/506  C-Reactive Protein, Human
92/510  Follicle Stimulating Hormone, Human, recombinant
08/258  Antithrombin, Plasma (3rd International Standard)
66/387  Anti-thyroid Microsome Serum, Human
06/202  HPV 16 DNA
06/206  HPV 18 DNA
94/572  Ferritin, Human, recombinant
RTF/16  Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016
83/575  Follicle Stimulating Hormone, Pituitary
73/601  Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation)
RAI  Anti-rabies Immunoglobulin, Human
80/505  Growth Hormone, Human, Pituitary
RUBI-1-94  Anti-rubella Immunoglobulin, Human
75/551  Chorionic Gonadotrophin beta Subunit, Human
09/162  Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard
81/535(80/552)  Luteinizing Hormone, Human, Pituitary
91/530  Epidermal Growth Factor (Human, rDNA derived)
09/264  Fibrinogen Plasma (D)(3rd International Standard)

NIBSC 标准品
Biotherapeutics
Cytokines and Growth Factors 
Endotoxin 
Haemostasis 
Immunogenicity 
Immunoglobulins and immune sera 
Protein Hormones and Endocrine Products 
Quality Control Reagent

UK Stem Cell Bank 
Mouse Embryo Fibroblasts

Diagnostics
Allergen 
Anti-Toxins 
Blood borne pathogens 
Blood Transfusion and Transplantation 
Ebola Virus 
Genomic Reference Material 
Haematinics and Haemoglobin 
Haemostasis 
Human Papillomavirus 
Immunoglobulins and immune sera 
Miscellaneous 
Parasitology 
Parvovirus 
Protein Hormones and Endocrine Products 
Quality Control Reagent 
Zoonosis and livestock diseases

Vaccines
Botulinum 
Clostridium 
Diphtheria 
Ebola Virus 
Enteric disease 
Haemophilus Influenzae type b (Hib) 
Human Papillomavirus 
Influenza 
JE/Dengue 
Malaria 
Meningococcal typing and ELISA reagents 
MMR 
Parasitology 
Pertussis 
Pneumococcal vaccines 
Polio 
Quality Control Reagent 
Staphylococcal Immune Sera 
Tetanus 
Tuberculosis 
Vaccinia 
Yellow Fever 
Zoonosis and livestock diseases

00/410 MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation)
International Reference Preparation 
00/416 Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
International Reference Preparation 
00/418 MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)
WHO International Standard 
00/422 High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
International Reference Preparation 
00/440 Influenza Antiserum A/Singapore/1/57 (H2)
Influenza Reagent 
00/442 Influenza anti B/Yamanashi/166/98 Serum
Influenza Reagent 
00/464 Streptokinase (3rd International Standard 2001)
WHO International Standard 
00/500 Botulinum Type A-E Antitoxin, Human Serum
Non WHO Reference Material 
00/530 Influenza Virus infectious B/Sichuan/379/99
Influenza Reagent 
00/542 Influenza anti- A/Chick/Scotland/59 (H5N1) Serum
Influenza Reagent 
00/544 Influenza Virus infectious B/Victoria/504/00
Influenza Reagent 
00/546 Influenza Antigen B/Johannesburg/5/99
Influenza Reagent 
00/552 Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3)
Influenza Reagent 
00/556 Influenza anti-B/Johannesburg/5/99/ Serum
Influenza Reagent 
00/562 Hepatitis A Virus for Nucleic Acid Amplification Techniques(2nd International Standard)
WHO International Standard 
00/572 Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard)
WHO International Standard 
00/574 Interferon Beta SER17 Mutein (Human, rDNA derived)
Non WHO Reference Material 
00/576 Interferon Beta (Human, Fibroblast-derived, Glycosylated)
Non WHO Reference Material 
00/614 Influenza virus infectious B/Guangdong/120/2000
Influenza Reagent 
007SP Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)
WHO International Standard 
01/412 Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody
Non WHO Reference Material 
01/420 Interleukin-17 (Human rDNA derived)(International Reference Reagent)
International Reference Reagent 
01/424 Vascular Endothelial Growth Factor, Human rDNA derived
Non WHO Reference Material 
01/426 Meningococcal group Y polysaccharide
Non WHO Reference Material 
01/428 Meningococcal serogroup W polysaccharide
Non WHO Reference Material 
01/450 Influenza anti B/Guangdong/120/2000 Serum
Influenza Reagent 
01/452 Influenza anti A/Panama/2007/99 (H3N2) HA serum
Influenza Reagent 
01/506 Botulinum type F antitoxin, equine
Non WHO Reference Material 
01/508 Botulinum type C antitoxin, equine
Non WHO Reference Material 
01/510 Botulinum Antitoxin Equine Type D
Non WHO Reference Material 
01/512 Botulinum type G antitoxin, equine
Non WHO Reference Material 
01/514 Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody
Non WHO Reference Material 
01/528 Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain] (Panel of 5 ampoules)
International Reference Preparation 
01/532 Oral Poliovaccine Sabin Type 3 reference strain (Panel of 5 ampoules)
International Reference Preparation 
01/538 Anti-Meningococcal Serosubtype P1.16 mAb
Non WHO Reference Material 
01/546 Influenza Antigen B/Guangdong/120/2000
Influenza Reagent 
01/572 Anti-D Immunoglobulin(2nd International Standard)
WHO International Standard 
01/580 Thrombin, human(2nd International Standard)
WHO International Standard 
01/600 Anti-Toxoplasma IgG, Human(International Standard)
WHO International Standard 
01/602 Anti-Parvovirus B19, plasma, human(2nd International Standard)
WHO International Standard 
01/612 Influenza Virus infectious B/Hawaii/10/01
Influenza Reagent 
01/614 Influenza Antigen A/New Caledonia/20/99
Influenza Reagent 
02/102 Influenza anti A/Panama/2007/99 Serum
Influenza Reagent 
02/144 Anti-Meningococcal Serosubtype P1.15 mAb
Non WHO Reference Material 
02/148 Anti-Meningococcal Serosubtype P1.4 mAb
Non WHO Reference Material 
02/168 Prekallikrein Activator (PKA), Human(2nd International Standard)
WHO International Standard 
02/178 Anti-Meningococcal Serosubtype P1.2 mAb
Non WHO Reference Material 
02/180 Anti-Meningococcal Serotype P2.2a mAb
Non WHO Reference Material 
02/182 Anti-Japanese Encephalitis Virus Plasma, Human
Non WHO Reference Material